A new approach aims to help breast cancer patients with heart risks take their pills consistently

NCT ID NCT06121453

Recruiting now Disease control Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests a multicomponent adherence intervention designed to help patients with metastatic breast cancer and cardiovascular disease take their endocrine therapy, CDK4/6 inhibitors, and heart medications as prescribed. The study enrolls 35 adults who have reported some nonadherence. Researchers will measure changes in medication adherence and quality of life, and explore how social factors affect medication use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a multicomponent adherence intervention (behavioral support to reduce barriers to medication use)
What this could lead to: If effective, this approach could improve medication adherence and health outcomes for patients managing both metastatic breast cancer and cardiovascular disease.
What could go wrong: This is a small, early-stage trial with only 35 participants, so results may not apply broadly. The intervention relies on self-report and pharmacy data, which may not capture full adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Columbia University Medical Center
RECRUITING

New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.